Managing congestive heart failure in a general hospital in Malaysia. Are we keeping pace with evidence?

Medical Journal of Malaysia

Volumn 61, Issue 3, 2006, Pages 278-283

  Chin, S P ^a,b   Sapari, S ^a   How, S H ^a   Sim, K H ^b  

^a HOSPITAL TENGKU AMPUAN AFZAN   (Malaysia)

^b SARAWAK GENERAL HOSPITAL   (Malaysia)

Author keywords

Compliance; Evidence based medicine; Heart failure; Medical therapy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; SPIRONOLACTONE;

ARTICLE; CONGESTIVE HEART FAILURE; EVIDENCE BASED MEDICINE; FOLLOW UP; GENERAL HOSPITAL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE;

ACUTE DISEASE; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; DIURETICS; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECEPTORS, ANGIOTENSIN;

EID: 33751556037     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995; 26: 1376-9 8.
2. CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 1987; 316: 1429-35.
3. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Eng J Med 1992; 327: 685-91.
4. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Eng J Med 1999; 314: 709-17.
5. Australia/New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997; 349: 375-80.
6. Packer M, Bristow MR, Cohn JR et al. Effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Eng J Med 1996; 334: 1349-55.
7. Chin S, Kharim S, Ghaffar A et al. Secondary prevention of cardiovascular disease and diabetes: still suboptimal in patients with myocardial infarction. J Intern Med 2001; 249: 181-2.
8. Freestone B, Rajaratnam R, Hussain N, Lip GYH. Admission with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol 2003; 91: 233-8.
9. Lip GYH, Sarwar S, Ahmad I et al. A survey of heart failure in general practice. The West Birmingham heart failure project. Eur J Gen Pract 1997; 3: 85-9.
10. Malaysian Clinical Practice Guidelines on Management of Heart Failure 2000.
11. Gerstein HC, Yusuf S, Mann JFE et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-59.
12. Mogensen CE, Neldam S, Tikkanen I et al. Randomized controlled trial of dual-blockade on rennin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candersartan and lisinopril albuminuria (CALM) study. Bri Med J 2000; 321: 1440-44.
13. Cohn JN, Johnson G, Zeische S, et al. for the Ve-HeFT II InvestigatorsA comparison of enalapril with hydralazine-isorsobide dinitrate in the treatment of chronic congestive heart failure. N Eng J Med 1991; 325: 303-10.
14. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991; 121: 1852-3.
15. Cowie MR, Wood DA, Coats AJS et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999; 20: 421-8.
16. Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-62.
17. Poole-Wilson PA, Swedberg K, Cleland JGF, et al., for the COMET Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial COMET: randomized controlled trial. Lancet 2003; 362: 7-13.